Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$0.22 - $8.4 $10,627 - $405,770
48,306 New
48,306 $11,000
Q2 2022

Aug 15, 2022

SELL
$0.42 - $0.65 $135,007 - $208,939
-321,446 Reduced 86.94%
48,306 $29,000
Q1 2022

May 11, 2022

BUY
$0.54 - $2.74 $3,737 - $18,963
6,921 Added 1.91%
369,752 $223,000
Q4 2021

Feb 11, 2022

SELL
$2.33 - $3.37 $13,218 - $19,118
-5,673 Reduced 1.54%
362,831 $969,000
Q3 2021

Nov 12, 2021

BUY
$2.52 - $2.99 $98,307 - $116,642
39,011 Added 11.84%
368,504 $1.02 Million
Q2 2021

Aug 11, 2021

SELL
$2.6 - $3.65 $68,640 - $96,360
-26,400 Reduced 7.42%
329,493 $939,000
Q1 2021

May 13, 2021

BUY
$2.73 - $4.5 $23,166 - $38,187
8,486 Added 2.44%
355,893 $1.22 Million
Q4 2020

Feb 09, 2021

SELL
$2.6 - $3.32 $5,597 - $7,147
-2,153 Reduced 0.62%
347,407 $917,000
Q3 2020

Nov 12, 2020

SELL
$2.46 - $4.27 $36,366 - $63,123
-14,783 Reduced 4.06%
349,560 $1.09 Million
Q2 2020

Aug 12, 2020

BUY
$1.45 - $4.3 $123,851 - $367,284
85,415 Added 30.62%
364,343 $1.5 Million
Q1 2020

May 06, 2020

BUY
$0.75 - $2.55 $74,023 - $251,679
98,698 Added 54.76%
278,928 $449,000
Q4 2019

Feb 14, 2020

BUY
$1.65 - $2.48 $26,535 - $39,883
16,082 Added 9.8%
180,230 $446,000
Q3 2019

Nov 07, 2019

SELL
$1.48 - $2.52 $28,278 - $48,149
-19,107 Reduced 10.43%
164,148 $275,000
Q2 2019

Aug 12, 2019

BUY
$2.45 - $3.32 $356,455 - $483,033
145,492 Added 385.28%
183,255 $458,000
Q1 2019

May 14, 2019

SELL
$2.52 - $3.24 $3,160 - $4,062
-1,254 Reduced 3.21%
37,763 $116,000
Q4 2018

Feb 11, 2019

BUY
$1.92 - $4.1 $32,509 - $69,421
16,932 Added 76.67%
39,017 $103,000
Q2 2018

Aug 06, 2018

SELL
$1.89 - $4.95 $15,987 - $41,872
-8,459 Reduced 27.69%
22,085 $87,000
Q1 2018

May 15, 2018

BUY
$2.06 - $2.38 $12,704 - $14,677
6,167 Added 25.3%
30,544 $64,000
Q4 2017

Feb 09, 2018

BUY
$1.91 - $2.83 $46,560 - $68,986
24,377
24,377 $51,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $385M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.